¡El sitio web de IMCAS tiene una nueva apariencia! Explore nuestro sitio web rediseñado. Estamos aquí para ayudarle a navegar por las nuevas funciones y agradecemos sus comentarios en contact@imcas.com.

Douglas SOLOMON

Finanzas corporativas

Estados Unidos

Biografía

Doug Solomon is a Managing Director in Barclays’ Global Healthcare Group, and manages and originates the firm’s medical technology business, a position he held at Lehman Brothers prior to its acquisition by Barclays. Prior to his role in medical technology banking, Doug was a senior member of the healthcare mergers and acquisitions practice at Lehman Brothers, executing transactions across various healthcare sub-verticals, including medical technology and life sciences. During his nearly 20 years in investment banking at Barclays/Lehman Brothers, Doug has led the execution of numerous M&A and capital markets transactions. Selected M&A experience includes Boston Scientific’s pending acquisition of BTG plc for $4.2 billion, Syneron’s sale to Apax Partners for ~$400 million, Allergan’s acquisition of LifeCell for $2.9 billion, Sage Products sale to Stryker for $2.775 billion, Welch Allyn’s sale to Hill-Rom for $2.05 billion, CareFusion’s sale to Becton Dickinson for $12.2 billion, Abbott’s acquisition of CFR Pharmaceuticals for $3.3 billion, Given Imaging’s sale to Covidien for $860 million, Stryker’s acquisition of Trauson for $685 million, the sale of Fenwal to Fresenius ($1.1 billion), Covidien’s acquisition of Oridion for $300 miilion, Fujifilm’s acquisition of SonoSite for $995 million, Stryker’s $1.5 billion acquisition of Boston Scientific’s neurovascular business, the $625 million sale of Datascope to Getinge AB, Centerpulse AGs $3.6 billion sale to Zimmer, the $3.9 billion merger of Apogent Technologies with Fisher Scientific, Esperion’s $1.3 billion sale to Pfizer and the $26 billion merger of CVS and Caremark. Doug earned his MBA from Columbia Business School and a BBA from Hofstra University.

Intereses principales (1)

Descubra IMCAS Academy

Seguir IMCAS

¿Necesita ayuda?

Política de privacidad Información legal
© 2025 IMCAS Curso Internacional de Maestría en Ciencias del Envejecimiento. Todos los derechos reservados.
Procesando, por favor espere...

Error

Por favor complete todos los campos requeridos. Estos son los campos que faltan: